Cleaning Efficacy of Skin Q Daily Gentle Cleanser with Gotu Kola Extract

A Clinical Study to Evaluate the Cleaning Efficacy of Skin Q Daily Gentle Cleanser with Gotu Kola Extract - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/07/114149

Enrollment

Registered

2026-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Skin Q Gentle Cleanser with Gotu Kola Extract: Dose: Apply pollution mix dirt on face evenly wait till it settle down on face, Wash the face with Cleanser thereafter conti

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject with the age between 18-45. 2. Subject with Normal Skin. 3. Subject willing to give written informed consent. 4. Woman of child Bearing potential must have a negative urine pregnancy Test. 5. Free of any systemic and dermatologic disorder, Which in the opinion of the investigator, will interface with the study results or increase the risk of AE. 6.Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation natural or artificial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subject who are pregnant, breast feeding, or Planning to become pregnant during the study. 2. Volunteers with skin conditions such as acute skin issues and dermatitis. 3. Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition. 4. Have Open score or open lesions in the treatment area. 5. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 6. Have participated in any interventional clinical trail in the previous 30 days. 7. Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents. 8. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications such as biologics, including corticosteroids. 9. Have a history of alcohol or illegal drug, substance abuse or suspected alcohol or illegal drug or substance abuse in the past 2 years.

Design outcomes

Primary

Measure	Time frame
1. Change in Hydration 2. Change in TEWL 3. Image with Dermascopy 4. Dermat Evaluation Timepoint: At Day 0, 30 min and Day 7	—

Secondary

Measure	Time frame
Change in skin pHTimepoint: At Day 0, 30 min;Subject Self-AssessmentTimepoint: At Day7	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results